what is mounjaro tirzepatide vs. Insulin: Which More Effective for Type 2 Diabetes? Tirzepatide (Mounjaro & Zepbound) for

But individual timing and use should be discussed with a healthcare provider

Head-to-Head Efficacy: STEP (Wegovy) vs SUSTAIN (Ozempic) Trial Data Explained Percent weight-loss, A1C changes, quality-of-life scores The pivotal STEP trials for Wegovy revealed striking weight-loss outcomes, with participants achieving an average body weight reduction of about 15% over 68 weeks

Edison P, Femminella G, Ritchie C, Holmes C, Walker Z, Ridha B, et al

High triglycerides represent one of the most common lipid abnormalities in people with obesity and insulin resistance, and this reduction addresses a genuine cardiovascular risk factor

On average, it might take 3 to 6 months to lose that amount of weight, depending on factors like dosage, individual metabolism, diet, and exercise levels.

It's assuming subcutaneous (SubQ) and intramuscular (IM) routes are interchangeable